Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cofilin 1 pseudogene 2 (CFL1P2) is a human pseudogene related to the gene encoding cofilin 1, an intracellular actin-binding protein involved in cytoskeleton remodeling[4]. CFL1P2 does not encode a functional cofilin protein and is not translated to yield an active product. Pseudogenes like CFL1P2 typically arise from duplication or retrotransposition events and lack the capacity for normal gene expression and protein function. CFL1P2 is not a target for therapeutic intervention, does not play a direct biological role, and has no pharmacological significance or known clinical relevance.\n\nIf you intended to ask about Cofilin 1 (CFL1), that is a protein-coding gene involved in actin filament dynamics with roles in processes such as cell motility, transcription, and disease; please clarify if you require information on the functional protein rather than the pseudogene[1][2][3][4].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cofilin 1 pseudogene 2 (CFL1P2).